• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Eliminated position


<











Is this an answer? What was the question?
Which salesforce is being labeled the 'overlay'?
So many questions...

I would say if I was in Neuro Science, then I might be worried. Ajovy can't stand on it's own legs in an already crowded migraine market. We don't need 3 sales forces selling Austedo.
 








Everyone that knows anything knows the overlays were only brought in temporarily and the NH weighting is 70/30 for 2024. What we need to know is what the new areas and regions look like? How many positions have been eliminated?
 




Everyone who knows anything knew this was gonna happen. Overlays were just an bandaid. More importantly, who’s not keeping their positions and what do the new regions look like? Let’s GO!